BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chintakuntlawar AV, Foote RL, Kasperbauer JL, Bible KC. Diagnosis and Management of Anaplastic Thyroid Cancer. Endocrinology and Metabolism Clinics of North America 2019;48:269-84. [DOI: 10.1016/j.ecl.2018.10.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Pang YL, Wang YP, Cheng K. Clinical Efficacy of Levothyroxine Sodium plus I 131 in the Treatment of Patients with Thyroidectomy and Its Effect on the Levels of Thyroglobulin and Thyrotropin. Evid Based Complement Alternat Med 2022;2022:9557061. [PMID: 35958920 DOI: 10.1155/2022/9557061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hatashima A, Archambeau B, Armbruster H, Xu M, Shah M, Konda B, Lott Limbach A, Sukrithan V. An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic Thyroid Carcinoma. Thyroid 2022;32:926-36. [PMID: 35583228 DOI: 10.1089/thy.2022.0073] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Huang D, Zhang J, Zheng X, Gao M. Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis. Front Endocrinol 2022;13:920857. [DOI: 10.3389/fendo.2022.920857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhao B, Aggarwal A, Im SY, Viswanathan K, Landa I, Nehs MA. Effect of Lactate Export Inhibition on Anaplastic Thyroid Cancer Growth and Metabolism. J Am Coll Surg 2022;234:1044-50. [PMID: 35703795 DOI: 10.1097/XCS.0000000000000226] [Reference Citation Analysis]
5 Li L, Cheng L, Sa R, Qiu X, Chen L. Real-world insights into the efficacy and safety of tyrosine kinase inhibitors against thyroid cancers. Crit Rev Oncol Hematol 2022;:103624. [PMID: 35150866 DOI: 10.1016/j.critrevonc.2022.103624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Moreno F, Reyes C, Pineda CA, Castellanos G, Cálix F, Calderón J, Vasquez-Bonilla WO. Anaplastic thyroid carcinoma with unusual long-term survival: a case report. J Med Case Rep 2022;16:39. [PMID: 35101107 DOI: 10.1186/s13256-021-03249-8] [Reference Citation Analysis]
7 李 守. Current Status of Targeted Therapy for Undifferentiated Thyroid Cancer. ACM 2022;12:804-809. [DOI: 10.12677/acm.2022.122117] [Reference Citation Analysis]
8 Wang H, Yu Y, Wang K, Sun H. Bibliometric Insights in Advances of Anaplastic Thyroid Cancer: Research Landscapes, Turning Points, and Global Trends. Front Oncol 2021;11:769807. [PMID: 34900720 DOI: 10.3389/fonc.2021.769807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kung FP, Lim YP, Chao WY, Zhang YS, Yu HI, Tai TS, Lu CH, Chen SH, Li YZ, Zhao PW, Yen YP, Lee YR. Piperlongumine, a Potent Anticancer Phytotherapeutic, Induces Cell Cycle Arrest and Apoptosis In Vitro and In Vivo through the ROS/Akt Pathway in Human Thyroid Cancer Cells. Cancers (Basel) 2021;13:4266. [PMID: 34503074 DOI: 10.3390/cancers13174266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Gilani SM, Khan M, Barbieri A, Prasad ML. Anaplastic thyroid carcinoma: diagnostic challenges, histopathologic features and ancillary testing. Diagnostic Histopathology 2021;27:263-271. [DOI: 10.1016/j.mpdhp.2021.03.004] [Reference Citation Analysis]
11 Ge MH, Zhu XH, Shao YM, Wang C, Huang P, Wang Y, Jiang Y, Maimaitiyiming Y, Chen E, Yang C, Naranmandura H. Synthesis and characterization of CD133 targeted aptamer-drug conjugates for precision therapy of anaplastic thyroid cancer. Biomater Sci 2021;9:1313-24. [PMID: 33350399 DOI: 10.1039/d0bm01832e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
12 Lin R, Ma B, Liu N, Zhang L, He T, Liu X, Chen T, Liu W, Liang Y, Wang T, Ni G, Liu X, Yang N, Zhang J, Yuan J. Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice. Ann Nucl Med 2021;35:811-22. [PMID: 33948902 DOI: 10.1007/s12149-021-01618-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Macerola E, Poma AM, Vignali P, Basolo A, Ugolini C, Torregrossa L, Santini F, Basolo F. Molecular Genetics of Follicular-Derived Thyroid Cancer. Cancers (Basel) 2021;13:1139. [PMID: 33799953 DOI: 10.3390/cancers13051139] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
14 Miller KC, Chintakuntlawar AV. Molecular-Driven Therapy in Advanced Thyroid Cancer. Curr Treat Options Oncol 2021;22:24. [PMID: 33569661 DOI: 10.1007/s11864-021-00822-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Abe I, Lam AK. Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging. Histol Histopathol 2021;36:239-48. [PMID: 33170501 DOI: 10.14670/HH-18-277] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
16 Kaya C, Dorsaint P, Mercurio S, Campbell AM, Eng KW, Nikiforova MN, Elemento O, Nikiforov YE, Sboner A. Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples. Thyroid 2021;31:589-95. [PMID: 32948110 DOI: 10.1089/thy.2020.0307] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
17 Song T, Chen L, Zhang H, Lu Y, Yu K, Zhan W, Fang M. Multimodal treatment based on thyroidectomy improves survival in patients with metastatic anaplastic thyroid carcinoma: a SEER analysis from 1998 to 2015. Gland Surg 2020;9:1205-13. [PMID: 33224795 DOI: 10.21037/gs-20-503] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 Cao J, Zhang M, Zhang L, Lou J, Zhou F, Fang M. Non-coding RNA in thyroid cancer - Functions and mechanisms. Cancer Lett 2021;496:117-26. [PMID: 32949678 DOI: 10.1016/j.canlet.2020.08.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
19 Kim SY, Kim SM, Kim JW, Lee IJ, Jeon TJ, Chang H, Kim BW, Lee YS, Chang HS, Park CS. Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis. Front Endocrinol (Lausanne) 2020;11:599. [PMID: 32982983 DOI: 10.3389/fendo.2020.00599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lombardo ME, Zito G, Pavia FC, Pizzolanti G, Giordano C, Brucato V, La Carrubba V. 3D polymeric supports promote the growth and progression of anaplastic thyroid carcinoma. Biochem Biophys Res Commun 2020;531:223-7. [PMID: 32798016 DOI: 10.1016/j.bbrc.2020.07.062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Alobuia W, Gillis A, Kebebew E. Contemporary Management of Anaplastic Thyroid Cancer. Curr Treat Options Oncol 2020;21:78. [PMID: 32767129 DOI: 10.1007/s11864-020-00776-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
22 Mai JYL, Ebrahimi A, Lee A, Kanjanapan Y, Perampalam S, Connors J, Chou W, Liang X. Response to multidisciplinary therapy of metastatic anaplastic thyroid cancer involving the right internal jugular vein and superior vena cava. ANZ J Surg 2021;91:E149-50. [PMID: 32761871 DOI: 10.1111/ans.16208] [Reference Citation Analysis]
23 Nylén C, Mechera R, Maréchal-Ross I, Tsang V, Chou A, Gill AJ, Clifton-Bligh RJ, Robinson BG, Sywak MS, Sidhu SB, Glover AR. Molecular Markers Guiding Thyroid Cancer Management. Cancers (Basel) 2020;12:E2164. [PMID: 32759760 DOI: 10.3390/cancers12082164] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
24 Kim M, Ahn J, Song DE, Yoon JH, Kang HC, Lim DJ, Kim WG, Kim TY, Kim WB, Shong YK, Jeon MJ, Kim BH. Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer. Endocrine 2021;71:427-33. [PMID: 32729092 DOI: 10.1007/s12020-020-02425-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
25 MacDonald L, Jenkins J, Purvis G, Lee J, Franco AT. The Thyroid Tumor Microenvironment: Potential Targets for Therapeutic Intervention and Prognostication. Horm Cancer 2020;11:205-17. [PMID: 32548798 DOI: 10.1007/s12672-020-00390-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
26 Di Desidero T, Orlandi P, Gentile D, Banchi M, Alì G, Kusmic C, Armanetti P, Cayme GJ, Menichetti L, Fontanini G, Francia G, Bocci G. Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer. Pharmacol Res 2020;158:104920. [PMID: 32461187 DOI: 10.1016/j.phrs.2020.104920] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
27 Tan X, Wang P, Lou J, Zhao J. Knockdown of lncRNA NEAT1 suppresses hypoxia-induced migration, invasion and glycolysis in anaplastic thyroid carcinoma cells through regulation of miR-206 and miR-599. Cancer Cell Int 2020;20:132. [PMID: 32336952 DOI: 10.1186/s12935-020-01222-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
28 Gentile D, Orlandi P, Banchi M, Bocci G. Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer. Med Oncol 2020;37. [DOI: 10.1007/s12032-020-1345-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Lungulescu C, Croitoru VM, Lungulescu C, Croitoru A, Paul D. DURABLE RESPONSE IN A CASE OF METASTATIC ANAPLASTIC THYROID CANCER USING A COMBINATION OF TYROSINE KINASE INHIBITORS AND A CHECK POINT INHIBITOR. Acta Endocrinol (Buchar) 2020;16:236-41. [PMID: 33029242 DOI: 10.4183/aeb.2020.236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Spalart V, Legius B, Segers K, Coolen J, Maes B, Decoster L. Dramatic Response to First Line Single Agent Pembrolizumab in Anaplastic Thyroid Carcinoma. Case Rep Endocrinol 2019;2019:9095753. [PMID: 31885948 DOI: 10.1155/2019/9095753] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
31 Schroader B, Kong S, Anderson S, Williamson T, Sireci A, Shields K. Current status of biomarker testing in historically rare, high-unmet-need tumors: soft tissue sarcomas and thyroid cancers. Expert Review of Anticancer Therapy 2019;19:929-38. [DOI: 10.1080/14737140.2019.1682554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Geng M, Yang Y, Cao X, Dang L, Zhang T, Zhang L. Targeting CDK12-mediated transcription regulation in anaplastic thyroid carcinoma. Biochem Biophys Res Commun 2019;520:544-50. [PMID: 31615655 DOI: 10.1016/j.bbrc.2019.10.052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
33 Eshraghi R, Barkan GA, Pambuccian SE. Rhabdoid cells in the fine needle aspirate of a neck mass in a patient with history of melanoma: Anaplastic thyroid carcinoma. Diagn Cytopathol 2019;47:1232-6. [PMID: 31348613 DOI: 10.1002/dc.24284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Führer D, Schmid KW, Dralle H. Anaplastisches Schilddrüsenkarzinom – Update 2019. Onkologe 2019;25:569-572. [DOI: 10.1007/s00761-019-0592-3] [Reference Citation Analysis]
35 Rossi ED, Faquin WC, Pantanowitz L. Cytologic features of aggressive variants of follicular-derived thyroid carcinoma. Cancer Cytopathol 2019;127:432-46. [PMID: 31150164 DOI: 10.1002/cncy.22136] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]